AAAAAA

   
Results: 1-16 |
Results: 16
Diagnosis and management of pre-core mutant chronic hepatitis B
Authors: Papatheodoridis, GV Hadziyannis, SJ
Citation: Gv. Papatheodoridis et Sj. Hadziyannis, Diagnosis and management of pre-core mutant chronic hepatitis B, J VIRAL HEP, 8(5), 2001, pp. 311-321
Management of recurrent hepatitis C after liver transplantation
Authors: Teixeira, R Papatheodoridis, GV Burroughs, AK
Citation: R. Teixeira et al., Management of recurrent hepatitis C after liver transplantation, J VIRAL HEP, 8(3), 2001, pp. 159-168
Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis.
Authors: Papatheodoridis, GV Papadimitropoulos, VC Hadziyannis, SJ
Citation: Gv. Papatheodoridis et al., Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis., ALIM PHARM, 15(5), 2001, pp. 689-698
The long-term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B
Authors: Papatheodoridis, GV Manesis, E Hadziyannis, SJ
Citation: Gv. Papatheodoridis et al., The long-term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B, J HEPATOL, 34(2), 2001, pp. 306-313
The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis
Authors: Papatheodoridis, GV Davies, S Dhillon, AP Teixeira, R Goulis, J Davidson, B Rolles, K Dusheiko, G Burroughs, AK
Citation: Gv. Papatheodoridis et al., The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis, TRANSPLANT, 72(3), 2001, pp. 412-418
Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B
Authors: Hadziyannis, SJ Papatheodoridis, GV Dimou, E Laras, A Papaioannou, C
Citation: Sj. Hadziyannis et al., Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B, HEPATOLOGY, 32(4), 2000, pp. 847-851
Recurrent hepatitis C after liver transplantation
Authors: Teixeira, R Pastacaldi, S Papatheodoridis, GV Burroughs, AK
Citation: R. Teixeira et al., Recurrent hepatitis C after liver transplantation, J MED VIROL, 61(4), 2000, pp. 443-454
Long-term outcome of chronic hepatitis C treated with interferon
Authors: Hadziyannis, SJ Papatheodoridis, GV
Citation: Sj. Hadziyannis et Gv. Papatheodoridis, Long-term outcome of chronic hepatitis C treated with interferon, ITAL J GAST, 31(6), 1999, pp. 459-461
p53 protein accumulation and colonic adenoma recurrence
Authors: Triantafyllou, K Paspatis, GA Zizi, A Papatheodoridis, GV Tzouvala, M Chlouverakis, GJ Elemenoglou, I Karamanolis, DG
Citation: K. Triantafyllou et al., p53 protein accumulation and colonic adenoma recurrence, EUR J GASTR, 11(5), 1999, pp. 547-552
Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis
Authors: Papatheodoridis, GV Goulis, J Leandro, G Patch, D Burroughs, AK
Citation: Gv. Papatheodoridis et al., Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis, HEPATOLOGY, 30(3), 1999, pp. 612-622
Infection and hemostasis in decompensated cirrhosis: A prospective study using thrombelastography
Authors: Papatheodoridis, GV Patch, D Webster, GJM Brooker, J Barnes, E Burroughs, AK
Citation: Gv. Papatheodoridis et al., Infection and hemostasis in decompensated cirrhosis: A prospective study using thrombelastography, HEPATOLOGY, 29(4), 1999, pp. 1085-1090
Transjugular liver biopsy in the 1990s: a 2-year audit
Authors: Papatheodoridis, GV Patch, D Watkinson, A Tibballs, J Burroughs, AK
Citation: Gv. Papatheodoridis et al., Transjugular liver biopsy in the 1990s: a 2-year audit, ALIM PHARM, 13(5), 1999, pp. 603-608
Correction of both prothrombin time and primary haemostasis by recombinantfactor VII during therapeutic alcohol injection of hepatocellular cancer in liver cirrhosis
Authors: Papatheodoridis, GV Chung, S Keshav, S Pasi, J Burroughs, AK
Citation: Gv. Papatheodoridis et al., Correction of both prothrombin time and primary haemostasis by recombinantfactor VII during therapeutic alcohol injection of hepatocellular cancer in liver cirrhosis, J HEPATOL, 31(4), 1999, pp. 747-750
The outcome of hepatitis C virus infection after liver transplantation - is it influenced by the type of immunosuppression?
Authors: Papatheodoridis, GV Patch, D Dusheiko, GM Burroughs, AK
Citation: Gv. Papatheodoridis et al., The outcome of hepatitis C virus infection after liver transplantation - is it influenced by the type of immunosuppression?, J HEPATOL, 30(4), 1999, pp. 731-738
Mycophenolate mofetil monotherapy in stable liver transplant patients withcyclosporine-induced renal impairment - A preliminary report
Authors: Papatheodoridis, GV O'Beirne, J Mistry, P Davidson, B Rolles, K Burroughs, AK
Citation: Gv. Papatheodoridis et al., Mycophenolate mofetil monotherapy in stable liver transplant patients withcyclosporine-induced renal impairment - A preliminary report, TRANSPLANT, 68(1), 1999, pp. 155-157
Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive regimens
Authors: Papatheodoridis, GV Barton, SGRG Andrew, D Clewley, G Davies, S Dhillon, AP Dusheiko, G Davidson, B Rolles, K Burroughs, AK
Citation: Gv. Papatheodoridis et al., Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive regimens, GUT, 45(3), 1999, pp. 427-434
Risultati: 1-16 |